The FDA is launching a pilot program to monitor clinical trials in real time using AI and cloud computing, a move the agency says could dramatically shorten the time it takes to approve new drugs. The article FDA bets on AI and cloud monitoring for clinical trials as it looks to rebuild after DOGE layoffs appeared first on The Decoder.